Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

JAMA Neurol. 2019 Sep 23. doi: 10.1001/jamaneurol.2019.2940. [Epub ahead of print]

PMID:
31545352
2.

Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis.

Wilbur C, Reginald YA, Longoni G, Grover SA, Wong AM, Mabbott DJ, Arnold DL, Marrie RA, Bar-Or A, Banwell B, Costello F, Yeh EA; Canadian Pediatric Demyelinating Disease Network.

Mult Scler Relat Disord. 2019 Sep 7;36:101387. doi: 10.1016/j.msard.2019.101387. [Epub ahead of print]

PMID:
31539739
3.

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.

Marrie RA, O'Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

PLoS One. 2019 Jun 11;14(6):e0218215. doi: 10.1371/journal.pone.0218215. eCollection 2019.

4.

A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.

Fadda G, Brown RA, Magliozzi R, Aubert-Broche B, O'Mahony J, Shinohara RT, Banwell B, Marrie RA, Yeh EA, Collins DL, Arnold DL, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Ann Neurol. 2019 Mar;85(3):340-351. doi: 10.1002/ana.25429. Epub 2019 Feb 20.

5.

Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.

Marrie RA, O'Mahony J, Maxwell C, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2018 Oct 23;91(17):e1579-e1590. doi: 10.1212/WNL.0000000000006395. Epub 2018 Sep 26.

PMID:
30258022
6.

MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.

Fadda G, Brown RA, Longoni G, Castro DA, O'Mahony J, Verhey LH, Branson HM, Waters P, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Lancet Child Adolesc Health. 2018 Mar;2(3):191-204. doi: 10.1016/S2352-4642(18)30026-9. Epub 2018 Feb 1.

PMID:
30169254
7.

Monophasic demyelination reduces brain growth in children.

Aubert-Broche B, Weier K, Longoni G, Fonov VS, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Verhey LH, Banwell B, Collins DL; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2017 May 2;88(18):1744-1750. doi: 10.1212/WNL.0000000000003884. Epub 2017 Apr 5.

8.

White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.

Longoni G, Brown RA, MomayyezSiahkal P, Elliott C, Narayanan S, Bar-Or A, Marrie RA, Yeh EA, Filippi M, Banwell B, Arnold DL; Canadian Pediatric Demyelinating Disease Network.

Brain. 2017 May 1;140(5):1300-1315. doi: 10.1093/brain/awx041.

PMID:
28334875
9.

Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.

Makhani N, Banwell B, Tellier R, Yea C, McGovern S, O'Mahony J, Ahorro JM, Arnold D, Sadovnick AD, Marrie RA, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Mult Scler. 2016 Mar;22(3):385-8. doi: 10.1177/1352458515595876. Epub 2015 Jul 21.

PMID:
26199356
10.

Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.

Quintana FJ, Patel B, Yeste A, Nyirenda M, Kenison J, Rahbari R, Fetco D, Hussain M, O'Mahony J, Magalhaes S, McGowan M, Johnson T, Rajasekharan S, Narayanan S, Arnold DL, Weiner HL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2014 Dec 9;83(24):2219-26. doi: 10.1212/WNL.0000000000001066. Epub 2014 Nov 7.

11.

Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients.

Brown RA, Narayanan S, Banwell B, Arnold DL; Canadian Pediatric Demyelinating Disease Network.

Neuroimage Clin. 2014 Sep 10;6:237-42. doi: 10.1016/j.nicl.2014.09.003. eCollection 2014.

12.

Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.

Aubert-Broche B, Fonov V, Narayanan S, Arnold DL, Araujo D, Fetco D, Till C, Sled JG, Banwell B, Collins DL; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2014 Dec 2;83(23):2140-6. doi: 10.1212/WNL.0000000000001045. Epub 2014 Nov 5.

13.

Functional-structural correlations in the afferent visual pathway in pediatric demyelination.

Yeh EA, Marrie RA, Reginald YA, Buncic JR, Noguera AE, O'Mahony J, Mah JK, Banwell B, Costello F; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2014 Dec 2;83(23):2147-52. doi: 10.1212/WNL.0000000000001046. Epub 2014 Oct 31.

14.

Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.

Ghassemi R, Narayanan S, Banwell B, Sled JG, Shroff M, Arnold DL; Canadian Pediatric Demyelinating Disease Network.

PLoS One. 2014 Feb 26;9(2):e85741. doi: 10.1371/journal.pone.0085741. eCollection 2014.

15.

Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.

Yiu EM, Laughlin S, Verhey LH, Banwell BL; Canadian Pediatric Demyelinating Disease Network.

J Child Neurol. 2014 May;29(5):654-65. doi: 10.1177/0883073813500713. Epub 2013 Oct 3.

PMID:
24092896
16.

Epstein-Barr virus in oral shedding of children with multiple sclerosis.

Yea C, Tellier R, Chong P, Westmacott G, Marrie RA, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2013 Oct 15;81(16):1392-9. doi: 10.1212/WNL.0b013e3182a841e4. Epub 2013 Sep 6.

17.

2010 McDonald criteria for diagnosing pediatric multiple sclerosis.

Sadaka Y, Verhey LH, Shroff MM, Branson HM, Arnold DL, Narayanan S, Sled JG, Bar-Or A, Sadovnick AD, McGowan M, Marrie RA, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Ann Neurol. 2012 Aug;72(2):211-23. doi: 10.1002/ana.23575.

PMID:
22926854
18.

A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples.

Belabani C, Rajasekharan S, Poupon V, Johnson T, Bar-Or A; CIHR/MSSC NET in Clinical Autoimmunity; Canadian Pediatric Demyelinating Disease Network.

J Immunol Methods. 2013 Jan 31;387(1-2):1-10. doi: 10.1016/j.jim.2012.08.002. Epub 2012 Aug 11.

PMID:
22917931
19.

Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program.

O'Mahony J, Bar-Or A, Arnold DL, Sadovnick AD, Marrie RA, Banwell B; Canadian Pediatric Demyelinating Disease Network.

J Child Neurol. 2013 Feb;28(2):184-97. doi: 10.1177/0883073812443006. Epub 2012 May 9.

PMID:
22573735
20.

MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.

Verhey LH, Branson HM, Shroff MM, Callen DJ, Sled JG, Narayanan S, Sadovnick AD, Bar-Or A, Arnold DL, Marrie RA, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Lancet Neurol. 2011 Dec;10(12):1065-73. doi: 10.1016/S1474-4422(11)70250-2. Epub 2011 Nov 6.

PMID:
22067635

Supplemental Content

Loading ...
Support Center